In immune thrombocytopenia, what is the initial treatment regimen to raise platelets above 50, with tapering?

Study for the PANCE Precision Exam. Improve with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your exam!

Multiple Choice

In immune thrombocytopenia, what is the initial treatment regimen to raise platelets above 50, with tapering?

Explanation:
Initial therapy in immune thrombocytopenia aims to raise the platelet count quickly to reduce bleeding risk. Corticosteroids, such as prednisone at 1 mg/kg per day, dampen the immune response, reducing autoantibody production and slowing the destruction of platelets. As platelets rise to a safer level (above about 50,000/µL), the dose is tapered over several weeks—roughly four—to minimize steroid-related side effects and to help prevent relapse. While other therapies like IVIG can lift platelets quickly, they are typically used when a rapid rise is needed or as a bridge, not as the initial long-term plan. Splenectomy and thrombopoietin receptor agonists are generally reserved for cases that do not respond to initial medical therapy.

Initial therapy in immune thrombocytopenia aims to raise the platelet count quickly to reduce bleeding risk. Corticosteroids, such as prednisone at 1 mg/kg per day, dampen the immune response, reducing autoantibody production and slowing the destruction of platelets. As platelets rise to a safer level (above about 50,000/µL), the dose is tapered over several weeks—roughly four—to minimize steroid-related side effects and to help prevent relapse. While other therapies like IVIG can lift platelets quickly, they are typically used when a rapid rise is needed or as a bridge, not as the initial long-term plan. Splenectomy and thrombopoietin receptor agonists are generally reserved for cases that do not respond to initial medical therapy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy